DM
BMRN icon

Deerfield Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Deerfield Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.1M Buy
+851,556
New +$49.7M 0.57% 47
2024
Q4 		– Sell
-9,255
Closed -$651K – 153
2024
Q3 		$651K Sell
9,255
-577
-6% -$48.2K 0.01% 241
2024
Q2 		$809K Buy
+9,832
New +$819K 0.01% 178
2021
Q1 		– Sell
-163,000
Closed -$14.3M – 136
2020
Q4 		$14.3M Buy
+163,000
New +$12.9M 0.28% 89
2016
Q4 		– Sell
-13,800
Closed -$1.28M – 103
2016
Q3 		$1.28M Buy
+13,800
New +$1.3M 0.06% 88
2013
Q3 		– Sell
-247,000
Closed -$13.8M – 119
2013
Q2 		$13.8M Buy
+247,000
New +$15.4M 0.7% 53

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return